Recently, BioDiscovery signed an OEM partnership deal with Thermo Fisher Scientific for analysis software for the OncoScan Assay. The partnership allows the two companies to merge their expertise in high-throughput genomic data analysis software and array based assays for the cancer genomics market. BioDiscovery developed Nexus Express for OncoScan software for Thermo Fisher's OncoScan CNV Assay for solid tumor analysis.
BioDiscovery was invited as a partner to exhibit its NxClinical software with Philips at the American Molecular Pathology (AMP) Annual Conference. BioDiscovery's NxClinical has been an established software tool in clinical labs for copy number variants analysis and reporting.
Dr. Breen of North Carolina State University has been a long time user of our Nexus Copy Number software and we were pleased to learn of his application of his latest patent: a new, non-invasive method of diagnosing bladder cancer in dogs.
NxClinical 3.0 was announced at ASHG and is the first comprehensive case review and reporting system that combines array and NGS data.
Our new version on NxClinical 3.0 offers something that no one else in this industry is currently offering which is uniting NGS and microarray data in one single database software system.
The Pre-launch of the newest version of NxClinical 3.0 was successfully celebrated yesterday at our open house party.